CompletedNot Applicable

Mat Pilates With Paced Breathing Versus Diaphragmatic Breathing in Stage II Hypertension

Pakistan63 participantsStarted 2025-09-15

Plain-language summary

This randomized controlled trial aims to compare the effects of mat Pilates combined with paced breathing versus mat Pilates combined with diaphragmatic breathing on stress, anxiety, cardiopulmonary endurance, dyspnea, and quality of life in patients with Stage II hypertension. Participants will be recruited from the Physiotherapy Department of the University of Lahore Teaching Hospital. Outcome measures will include DASS-21, 6-Minute Walk Test (6MWT), Modified Borg Dyspnea Scale, and SF-12 Health Survey. The intervention will be conducted three times per week for six weeks.

Who can participate

Age range40 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 40 to 50 years * Clinically diagnosed Stage II hypertension confirmed by a qualified healthcare provider * On a stable antihypertensive medication regimen for at least 4 weeks * Moderate dyspnea levels as measured by the Modified Borg Dyspnea Scale * Not currently participating in any structured exercise or rehabilitation program * Able to understand instructions and complete questionnaires * Willing to provide written informed consent Exclusion Criteria: * Uncontrolled hypertension (e.g., blood pressure greater than 180/110 mmHg) * History of recent cardiovascular events (e.g., myocardial infarction within the past 6 months) * Severe neurological or musculoskeletal disorders limiting mobility * Severe anxiety or stress requiring psychiatric intervention * Severe cognitive impairment or communication barriers * Currently enrolled in another clinical trial or structured wellness program * Any medical contraindication to physical activity as advised by a physician

What they're measuring

Stress and Anxiety Levels (DASS-21)

Timeframe: Baseline and at 6 weeks

Trial details

NCT IDNCT07433790

SponsorUniversity of Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-15